Compared with routine care, weight loss surgery was linked with a reduced risk of hypertension, heart failure, and early death in a study based on information from a primary care database in the UK. The findings are published in BJS (British Journal of Surgery).
Compared with routine care, weight loss surgery was linked with a reduced risk of hypertension, heart failure, and early death in a study based on information from a primary care database in the UK. The findings are published in BJS (British Journal of Surgery).
Although clinical studies have shown that weight loss surgery may reduce the risk of developing and dying from cardiovascular disease, studies using real-world data are limited. In the BJS study, investigators analysed data on 5,170 patients with obesity who underwent weight loss surgery and 9,995 patients with obesity who received only routine care.
Patients who underwent surgery had a 30% lower risk of dying from any cause, a 59% lower risk of developing hypertension, and a 43% lower risk of developing heart failure, compared with patients who did not undergo surgery.
Also, patients who underwent gastric bypass surgery—a specific kind of weight loss surgery—had a lower risk of cardiovascular diseases in general compared with patients who did not have surgery.
“Obesity is a chronic disease that is associated with many comorbidities and complications. Our results show the benefits of weight loss surgery in reducing the health burdens of obesity in real-world data,” said senior author Abd A. Tahrani, MD, of Queen Elizabeth Hospital, in the UK. “This is important considering the lower provision and availability of weight loss surgery in the UK compared with other European countries that have a lower prevalence of obesity. Weight loss surgery is an important treatment option in people with obesity, and improved access can help reduce the burden of this disease.”
This study publishes with a related article in BJS:
Almazeedi S, El-Abd R, Al-Khamis A, Albatineh AN, Al-Sabah S. Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis. DOI: 10.1002/bjs.11494
Additional Information
Link to Study: https://bjssjournals.onlinelibrary.wiley.com/doi/10.1002/bjs.11433
About Journal
With an impact factor of 5.572, BJS is the premier surgical journal in Europe and one of the top six surgical periodicals in the world. Its international readership is reflected in the prestigious international Editorial Board, supported by a panel of over 1200 reviewers worldwide.
BJS features the very best in clinical and laboratory-based research on all aspects of general surgery and related topics. Developing areas such as minimally invasive therapy and interventional radiology are strongly represented.
About Wiley
Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com